Protein kinase inhibitors of the quinazoline class exert anti-cytomegaloviral activity in vitro and in vivo.
Schleiss M, Eickhoff J, Auerochs S, Leis M, Abele S, Rechter S, Choi Y, Anderson J, Scott G, Rawlinson W, Michel D, Ensminger S, Klebl B, Stamminger T, Marschall M.
Schleiss M, et al.
Antiviral Res. 2008 Jul;79(1):49-61. doi: 10.1016/j.antiviral.2008.01.154. Epub 2008 Feb 22.
Antiviral Res. 2008.
PMID: 18329738